[HTML][HTML] The principles of engineering immune cells to treat cancer
WA Lim, CH June - Cell, 2017 - cell.com
Chimeric antigen receptor (CAR) T cells have proven that engineered immune cells can
serve as a powerful new class of cancer therapeutics. Clinical experience has helped to …
serve as a powerful new class of cancer therapeutics. Clinical experience has helped to …
Update on the use of immunoglobulin in human disease: a review of evidence
EE Perez, JS Orange, F Bonilla, J Chinen… - Journal of Allergy and …, 2017 - Elsevier
Human immunoglobulin preparations for intravenous or subcutaneous administration are
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …
Human T-bet governs the generation of a distinct subset of CD11chighCD21low B cells
High-level expression of the transcription factor T-bet characterizes a phenotypically distinct
murine B cell population known as “age-associated B cells”(ABCs). T-bet–deficient mice …
murine B cell population known as “age-associated B cells”(ABCs). T-bet–deficient mice …
Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention
JP Lynch III, AE Kajon - Seminars in respiratory and critical care …, 2016 - thieme-connect.com
Adenoviruses (AdVs) are DNA viruses that typically cause mild infections involving the
upper or lower respiratory tract, gastrointestinal tract, or conjunctiva. Rare manifestations of …
upper or lower respiratory tract, gastrointestinal tract, or conjunctiva. Rare manifestations of …
Acalabrutinib (ACP-196): a covalent Bruton tyrosine kinase inhibitor with a differentiated selectivity and in vivo potency profile
T Barf, T Covey, R Izumi, B van de Kar… - … of Pharmacology and …, 2017 - ASPET
Several small-molecule Bruton tyrosine kinase (BTK) inhibitors are in development for B cell
malignancies and autoimmune disorders, each characterized by distinct potency and …
malignancies and autoimmune disorders, each characterized by distinct potency and …
Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies
S Niewiesk - Frontiers in immunology, 2014 - frontiersin.org
Neonates have an immature immune system, which cannot adequately protect against
infectious diseases. Early in life, immune protection is accomplished by maternal antibodies …
infectious diseases. Early in life, immune protection is accomplished by maternal antibodies …
Targeting Bruton's tyrosine kinase in B cell malignancies
RW Hendriks, S Yuvaraj, LP Kil - Nature Reviews Cancer, 2014 - nature.com
Bruton's tyrosine kinase (BTK) is a key component of B cell receptor (BCR) signalling and
functions as an important regulator of cell proliferation and cell survival in various B cell …
functions as an important regulator of cell proliferation and cell survival in various B cell …
Health disparities in allergic and immunologic conditions in racial and ethnic underserved populations: a Work Group Report of the AAAAI Committee on the …
Health disparities are health differences linked with economic, social, and environmental
disadvantage. They adversely affect groups that have systematically experienced greater …
disadvantage. They adversely affect groups that have systematically experienced greater …
Bruton's tyrosine kinase: an emerging key player in innate immunity
ANR Weber, Z Bittner, X Liu, TM Dang… - Frontiers in …, 2017 - frontiersin.org
Bruton's tyrosine kinase (BTK) was initially discovered as a critical mediator of B cell
receptor signaling in the development and functioning of adaptive immunity. Growing …
receptor signaling in the development and functioning of adaptive immunity. Growing …
Current understanding of natural antibodies and exploring the possibilities of modulation using veterinary models. A review
GIJ Reyneveld, HFJ Savelkoul… - Frontiers in …, 2020 - frontiersin.org
Natural antibodies (NAb) are defined as germline encoded immunoglobulins found in
individuals without (known) prior antigenic experience. NAb bind exogenous (eg, bacterial) …
individuals without (known) prior antigenic experience. NAb bind exogenous (eg, bacterial) …